{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:12:04Z","timestamp":1790665924947,"version":"4.1.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132524"],"award-info":[{"award-number":["1132524"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1079679"],"award-info":[{"award-number":["1079679"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00401-019-02035-7","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T15:02:37Z","timestamp":1560610957000},"page":"705-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Cellular and regional vulnerability in frontotemporal tauopathies"],"prefix":"10.1007","volume":"138","author":[{"given":"Shelley L.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian J.","family":"Kril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-8398","authenticated-orcid":false,"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2035_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","volume":"126","author":"Z Ahmed","year":"2013","unstructured":"Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B et al (2013) Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol 126:537\u2013544. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1171-0","journal-title":"Acta Neuropathol"},{"key":"2035_CR2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","volume":"127","author":"Z Ahmed","year":"2014","unstructured":"Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667\u2013683","journal-title":"Acta Neuropathol"},{"key":"2035_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-011-0857-4","volume":"122","author":"Z Ahmed","year":"2011","unstructured":"Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, Mamais A, Hondhamuni G, Wray S, Newcombe J, O\u2019Sullivan SS et al (2011) Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. Acta Neuropathol 122:415\u2013428. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0857-4","journal-title":"Acta Neuropathol"},{"key":"2035_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","volume":"89","author":"D Alcolea","year":"2017","unstructured":"Alcolea D, Vilaplana E, Suarez-Calvet M, Illan-Gala I, Blesa R, Clarimon J, Llado A, Sanchez-Valle R et al (2017) CSF sAPPbeta, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology 89:178\u2013188. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004088","journal-title":"Neurology"},{"key":"2035_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00415-017-8644-3","volume":"265","author":"F Ali","year":"2018","unstructured":"Ali F, Josephs KA (2018) Corticobasal degeneration: key emerging issues. J Neurol 265:439\u2013445. \n                    https:\/\/doi.org\/10.1007\/s00415-017-8644-3","journal-title":"J Neurol"},{"key":"2035_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27619","author":"F Ali","year":"2019","unstructured":"Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A et al (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. \n                    https:\/\/doi.org\/10.1002\/mds.27619","journal-title":"Mov Disord"},{"key":"2035_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","volume":"132","author":"M Allen","year":"2016","unstructured":"Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S et al (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132:197\u2013211","journal-title":"Acta Neuropathol"},{"key":"2035_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-018-1900-5","volume":"136","author":"M Allen","year":"2018","unstructured":"Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG et al (2018) Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol 136:709\u2013727","journal-title":"Acta Neuropathol"},{"key":"2035_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004010000283","volume":"101","author":"T Arai","year":"2001","unstructured":"Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C et al (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick\u2019s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101:167\u2013173","journal-title":"Acta Neuropathol"},{"key":"2035_CR10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1440-1789.2006.00669.x","volume":"26","author":"K Arima","year":"2006","unstructured":"Arima K (2006) Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26:475\u2013483","journal-title":"Neuropathology"},{"key":"2035_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1","journal-title":"Neurology"},{"key":"2035_CR12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","volume":"21","author":"SE Arnold","year":"2000","unstructured":"Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ (2000) Quantitative neurohistological features of frontotemporal degeneration. Neurobiol Aging 21:913\u2013919","journal-title":"Neurobiol Aging"},{"key":"2035_CR13","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1002\/cne.23430","volume":"521","author":"SE Arnold","year":"2013","unstructured":"Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y, Wolk DA, Lee EB, Miller BL et al (2013) Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. J Comp Neurol 521:4339\u20134355. \n                    https:\/\/doi.org\/10.1002\/cne.23430","journal-title":"J Comp Neurol"},{"key":"2035_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663\u2013672. \n                    https:\/\/doi.org\/10.1038\/nrn2194","journal-title":"Nat Rev Neurosci"},{"key":"2035_CR15","first-page":"27","volume":"40","author":"F Beretti","year":"2017","unstructured":"Beretti F, Ardizzoni A, Cermelli C, Guida M, Maraldi T, Pietrosemoli P, Paulone S, De Pol A, Blasi E et al (2017) Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin. New Microbiol 40:27\u201332","journal-title":"New Microbiol"},{"key":"2035_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41398-017-0049-7","volume":"8","author":"LW Bonham","year":"2018","unstructured":"Bonham LW, Karch CM, Fan CC, Tan C, Geier EG, Wang Y (2018) CXCR16 involvement in neurodegenerative diseases. Transl Psychiatry 8:73","journal-title":"Transl Psychiatry"},{"key":"2035_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000480077","volume":"44","author":"S Borrego-Ecija","year":"2017","unstructured":"Borrego-Ecija S, Morgado J, Palencia-Madrid L, Grau-Rivera O, Rene R, Hernandez I, Almenar C, Balasa M, Antonell A et al (2017) Frontotemporal dementia caused by the p301l mutation in the mapt gene: clinicopathological features of 13 cases from the same geographical origin in Barcelona, Spain. Dement Geriatr Cogn Disord 44:213\u2013221. \n                    https:\/\/doi.org\/10.1159\/000480077","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2035_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s004010051077","volume":"98","author":"G Botez","year":"1999","unstructured":"Botez G, Probst A, Ipsen S, Tolnay M (1999) Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol 98:251\u2013256","journal-title":"Acta Neuropathol"},{"key":"2035_CR19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s007020050096","volume":"105","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801\u2013819","journal-title":"J Neural Transm"},{"key":"2035_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2035_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e318232a379","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR22","doi-asserted-by":"publisher","first-page":"e1002487","DOI":"10.1371\/journal.pmed.1002487","volume":"15","author":"I Broce","year":"2018","unstructured":"Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CH, Kouri N, Ross OA et al (2018) Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies. PLoS Med 15:e1002487. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1002487","journal-title":"PLoS Med"},{"key":"2035_CR23","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/brain\/awh250","volume":"127","author":"M Broe","year":"2004","unstructured":"Broe M, Kril J, Halliday GM (2004) Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127:2214\u20132220. \n                    https:\/\/doi.org\/10.1093\/brain\/awh250","journal-title":"Brain"},{"key":"2035_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Buee","year":"2000","unstructured":"Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Brain Res Rev"},{"key":"2035_CR25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1999.tb00550.x","volume":"9","author":"L Buee","year":"1999","unstructured":"Buee L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick\u2019s disease. Brain Pathol 9:681\u2013693","journal-title":"Brain Pathol"},{"key":"2035_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s004010050436","volume":"91","author":"V Buee Scherrer","year":"1996","unstructured":"Buee Scherrer V, Hof PR, Buee L, Leveugle B, Vermersch P, Perl DP, Olanow CW et al (1996) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick\u2019s disease. Acta Neuropathol 91:351\u2013359","journal-title":"Acta Neuropathol"},{"key":"2035_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.dadm.2016.03.006","volume":"4","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, Forrest S, Bak TH, Hodges JR, Halliday GM, Kril JJ (2016) Expanding the phenotypic associations of globular glial tau subtypes. Alzheimers Dement (Amst) 4:6\u201313. \n                    https:\/\/doi.org\/10.1016\/j.dadm.2016.03.006","journal-title":"Alzheimers Dement (Amst)"},{"key":"2035_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.25872","volume":"29","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hodges JR, Rowe JB (2014) Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29:684\u2013693. \n                    https:\/\/doi.org\/10.1002\/mds.25872","journal-title":"Mov Disord"},{"key":"2035_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ (2018) Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562:578\u2013582. \n                    https:\/\/doi.org\/10.1038\/s41586-018-0543-y","journal-title":"Nature"},{"key":"2035_CR30","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.neurobiolaging.2007.05.002","volume":"29","author":"TM Caffrey","year":"2008","unstructured":"Caffrey TM, Joachim C, Wade-Martins R (2008) Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Neurobiol Aging 29:1923\u20131929. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.05.002","journal-title":"Neurobiol Aging"},{"key":"2035_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5\u201322. \n                    https:\/\/doi.org\/10.1007\/s00401-007-0237-2","journal-title":"Acta Neuropathol"},{"key":"2035_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jnnp-2013-306948","volume":"85","author":"L Chare","year":"2014","unstructured":"Chare L, Hodges JR, Leyton CE, McGinley C, Tan RH, Kril JJ, Halliday GM (2014) New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry 85:865\u2013870. \n                    https:\/\/doi.org\/10.1136\/jnnp-2013-306948","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2035_CR33","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1021\/bi3010818","volume":"51","author":"B Combs","year":"2012","unstructured":"Combs B, Gamblin TC (2012) FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions. Biochemistry 51:8597\u20138607. \n                    https:\/\/doi.org\/10.1021\/bi3010818","journal-title":"Biochemistry"},{"key":"2035_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"2035_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1212\/WNL.0b013e3181c7198e","volume":"74","author":"V Deramecourt","year":"2010","unstructured":"Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, Buee L, Maurage CA, Pasquier F (2010) Prediction of pathology in primary progressive language and speech disorders. Neurology 74:42\u201349. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181c7198e","journal-title":"Neurology"},{"key":"2035_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0481","author":"SL DeVos","year":"2017","unstructured":"DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T et al (2017) Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aag0481","journal-title":"Sci Transl Med"},{"key":"2035_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394\u2013400. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e32833be924","journal-title":"Curr Opin Neurol"},{"key":"2035_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Kouri N, Murray ME, Josephs KA (2011) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384\u2013389. \n                    https:\/\/doi.org\/10.1007\/s12031-011-9589-0","journal-title":"J Mol Neurosci"},{"key":"2035_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2018.11.010","volume":"396","author":"CA Durkee","year":"2019","unstructured":"Durkee CA, Araque A (2019) Diversity and Specificity of astrocyte-neuron communication. Neuroscience 396:73\u201378. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2018.11.010","journal-title":"Neuroscience"},{"key":"2035_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","volume":"129","author":"C Duyckaerts","year":"2015","unstructured":"Duyckaerts C, Braak H, Brion JP, Buee L, Del Tredici K, Goedert M, Halliday G, Neumann M, Spillantini MG et al (2015) PART is part of Alzheimer disease. Acta Neuropathol 129:749\u2013756. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1390-7","journal-title":"Acta Neuropathol"},{"key":"2035_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","volume":"87","author":"MM Evers","year":"2015","unstructured":"Evers MM, Toonen LJ, van Roon-Mom WM (2015) Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev 87:90\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.addr.2015.03.008","journal-title":"Adv Drug Deliv Rev"},{"key":"2035_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/bmm.12.42","volume":"6","author":"AM Fagan","year":"2012","unstructured":"Fagan AM, Perrin RJ (2012) Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. Biomark Med 6:455\u2013476. \n                    https:\/\/doi.org\/10.2217\/bmm.12.42","journal-title":"Biomark Med"},{"key":"2035_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B et al (2018) Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561:137\u2013140. \n                    https:\/\/doi.org\/10.1038\/s41586-018-0454-y","journal-title":"Nature"},{"key":"2035_CR44","doi-asserted-by":"publisher","first-page":"e1511","DOI":"10.1016\/j.neurobiolaging.2014.01.010","volume":"35","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Ryten M, Simone R, Trabzuni D, Nicolaou N, Hondhamuni G et al (2014) Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol Aging 35:e1511\u2013e1512. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.010","journal-title":"Neurobiol Aging"},{"key":"2035_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/nen.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R et al (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81\u201397. \n                    https:\/\/doi.org\/10.1097\/nen.0000000000000030","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR46","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/brain\/awm305","volume":"131","author":"I Ferrer","year":"2008","unstructured":"Ferrer I, Santpere G, van Leeuwen FW (2008) Argyrophilic grain disease. Brain 131:1416\u20131432. \n                    https:\/\/doi.org\/10.1093\/brain\/awm305","journal-title":"Brain"},{"key":"2035_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.dadm.2018.12.001","volume":"11","author":"SL Forrest","year":"2019","unstructured":"Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR et al (2019) Heritability in frontotemporal tauopathies. Alzheimers Dement (Amst) 11:115\u2013124. \n                    https:\/\/doi.org\/10.1016\/j.dadm.2018.12.001","journal-title":"Alzheimers Dement (Amst)"},{"key":"2035_CR48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2018","unstructured":"Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV et al (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521\u2013534","journal-title":"Brain"},{"key":"2035_CR49","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain 130:2616\u20132635. \n                    https:\/\/doi.org\/10.1093\/brain\/awm177","journal-title":"Brain"},{"key":"2035_CR50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awz026","volume":"142","author":"N Franzmeier","year":"2019","unstructured":"Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL et al (2019) Functional connectivity associated with tau levels in ageing, Alzheimer\u2019s, and small vessel disease. Brain 142:1093\u20131107","journal-title":"Brain"},{"key":"2035_CR51","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu H, Hardy J, Duff KE (2018) Selective vulnerability in neurodegenerative diseases. Nat Neurosci 21:1350\u20131358. \n                    https:\/\/doi.org\/10.1038\/s41593-018-0221-2","journal-title":"Nat Neurosci"},{"key":"2035_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.parkreldis.2014.10.028","volume":"21","author":"S Fujioka","year":"2015","unstructured":"Fujioka S, Sanchez Contreras MY, Strongosky AJ, Ogaki K, Whaley NR, Tacik PM et al (2015) Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism Relat Disord 21:101\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.028","journal-title":"Parkinsonism Relat Disord"},{"key":"2035_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-016-1644-z","volume":"133","author":"JL Furman","year":"2017","unstructured":"Furman JL, Vaquer-Alicea J, White CL 3rd, Cairns NJ, Nelson PT, Diamond MI (2017) Widespread tau seeding activity at early Braak stages. Acta Neuropathol 133:91\u2013100. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1644-z","journal-title":"Acta Neuropathol"},{"key":"2035_CR54","doi-asserted-by":"publisher","first-page":"e0153852","DOI":"10.1371\/journal.pone.0153852","volume":"11","author":"C Gasca-Salas","year":"2016","unstructured":"Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE, Kleiner-Fisman G (2016) Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis. PLoS One 11:e0153852. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0153852","journal-title":"PLoS One"},{"key":"2035_CR55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1083\/jcb.201007161","volume":"192","author":"A Gauthier-Kemper","year":"2011","unstructured":"Gauthier-Kemper A, Weissmann C, Golovyashkina N, Sebo-Lemke Z, Drewes G, Gerke V, Heinisch JJ et al (2011) The frontotemporal dementia mutation R406\u00a0W blocks tau\u2019s interaction with the membrane in an annexin A2-dependent manner. J Cell Biol 192:647\u2013661. \n                    https:\/\/doi.org\/10.1083\/jcb.201007161","journal-title":"J Cell Biol"},{"key":"2035_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12213","volume":"41","author":"B Ghetti","year":"2015","unstructured":"Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M (2015) Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41:24\u201346. \n                    https:\/\/doi.org\/10.1111\/nan.12213","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR57","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-171115","volume":"63","author":"MJ Gil","year":"2018","unstructured":"Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C et al (2018) Argyrophilic grain pathology in frontotemporal lobar degeneration: demographic, clinical, neuropathological, and genetic features. J Alzheimers Dis 63:1109\u20131117. \n                    https:\/\/doi.org\/10.3233\/JAD-171115","journal-title":"J Alzheimers Dis"},{"key":"2035_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2018.10.024","volume":"58","author":"MJ Gil","year":"2018","unstructured":"Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M et al (2018) Frontotemporal lobar degeneration: study of a clinicopathological cohort. J Clin Neurosci 58:172\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2018.10.024","journal-title":"J Clin Neurosci"},{"key":"2035_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5414\/np301122","volume":"38","author":"MJ Gil","year":"2019","unstructured":"Gil MJ, Serrano S, Manzano MS, Cuadrado ML, Gomez E, Rabano A (2019) Argyrophilic grain disease presenting as behavioral frontotemporal dementia. Clin Neuropathol 38:8\u201313. \n                    https:\/\/doi.org\/10.5414\/np301122","journal-title":"Clin Neuropathol"},{"key":"2035_CR60","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1212\/01.wnl.0000187068.92184.63","volume":"65","author":"JS Goldman","year":"2005","unstructured":"Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM et al (2005) Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65:1817\u20131819. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000187068.92184.63","journal-title":"Neurology"},{"key":"2035_CR61","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1074\/mcp.M115.050724","volume":"14","author":"CG Gunawardana","year":"2015","unstructured":"Gunawardana CG, Mehrabian M, Wang X, Mueller I, Lubambo IB, Jonkman JE, Wang H et al (2015) The human Tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome. Mol Cell Proteom 14:3000\u20133014. \n                    https:\/\/doi.org\/10.1074\/mcp.M115.050724","journal-title":"Mol Cell Proteom"},{"key":"2035_CR62","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0250","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labbe C, Soto AI, Koga S, DeTure MA, Murray ME et al (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2019.0250","journal-title":"JAMA Neurol"},{"key":"2035_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"2035_CR64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/brain\/awp248","volume":"133","author":"JR Hodges","year":"2010","unstructured":"Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P et al (2010) Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 133:300\u2013306. \n                    https:\/\/doi.org\/10.1093\/brain\/awp248","journal-title":"Brain"},{"key":"2035_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mdc3.12582","volume":"5","author":"GU Hoglinger","year":"2018","unstructured":"Hoglinger GU (2018) Is it useful to classify progressive supranuclear palsy and corticobasal degeneration as different disorders? No. Mov Disord Clin Pract 5:141\u2013144. \n                    https:\/\/doi.org\/10.1002\/mdc3.12582","journal-title":"Mov Disord Clin Pract"},{"key":"2035_CR66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705. \n                    https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"2035_CR67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"2035_CR68","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914\u20131917","journal-title":"Science"},{"key":"2035_CR69","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE et al (2016) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79:272\u2013287. \n                    https:\/\/doi.org\/10.1002\/ana.24559","journal-title":"Ann Neurol"},{"key":"2035_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM (2018) Dendritic Tau in Alzheimer\u2019s disease. Neuron 99:13\u201327. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2018.06.003","journal-title":"Neuron"},{"key":"2035_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","volume":"7","author":"S Jadhav","year":"2019","unstructured":"Jadhav S, Avila J, Scholl M, Kovacs GG, Kovari E, Skrabana R et al (2019) A walk through tau therapeutic strategies. Acta Neuropathol Commun 7:22. \n                    https:\/\/doi.org\/10.1186\/s40478-019-0664-z","journal-title":"Acta Neuropathol Commun"},{"key":"2035_CR72","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-018-1894-z","volume":"136","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Different patterns of hippocampal tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol 136:811\u2013813. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1894-z","journal-title":"Acta Neuropathol"},{"key":"2035_CR73","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","volume":"129","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF et al (2015) PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol 129:757\u2013762. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1407-2","journal-title":"Acta Neuropathol"},{"key":"2035_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-006-0156-7","volume":"113","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Attems J (2007) Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol 113:107\u2013117. \n                    https:\/\/doi.org\/10.1007\/s00401-006-0156-7","journal-title":"Acta Neuropathol"},{"key":"2035_CR75","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/acn3.601","volume":"5","author":"LC Jiskoot","year":"2018","unstructured":"Jiskoot LC, Bocchetta M, Nicholas JM, Cash DM, Thomas D, Modat M et al (2018) Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: a cross-sectional diffusion tensor imaging study. Ann Clin Transl Neurol 5:1025\u20131036","journal-title":"Ann Clin Transl Neurol"},{"key":"2035_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM et al (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137\u2013153. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0839-6","journal-title":"Acta Neuropathol"},{"key":"2035_CR77","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.jnen.0000218446.38158.61","volume":"65","author":"KA Josephs","year":"2006","unstructured":"Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, Uitti RJ, Fujino Y et al (2006) Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 65:396\u2013405. \n                    https:\/\/doi.org\/10.1097\/01.jnen.0000218446.38158.61","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR78","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neurobiolaging.2006.10.032","volume":"29","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Whitwell JL, Parisi JE, Knopman DS, Boeve BF, Geda YE et al (2008) Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 29:566\u2013573","journal-title":"Neurobiol Aging"},{"key":"2035_CR79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","volume":"136","author":"SK Kaufman","year":"2018","unstructured":"Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI (2018) Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol 136:57\u201367","journal-title":"Acta Neuropathol"},{"key":"2035_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-004-0917-0","volume":"108","author":"C Kersaitis","year":"2004","unstructured":"Kersaitis C, Halliday GM, Kril JJ (2004) Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without pick bodies. Acta Neuropathol 108:515\u2013523. \n                    https:\/\/doi.org\/10.1007\/s00401-004-0917-0","journal-title":"Acta Neuropathol"},{"key":"2035_CR81","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jamaneurol.2016.0880","volume":"73","author":"S Kielb","year":"2016","unstructured":"Kielb S, Cook A, Wieneke C, Rademaker A, Bigio EH, Mesulam MM et al (2016) Neuropathologic associations of learning and memory in primary progressive aphasia. JAMA Neurol 73:846\u2013852. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.0880","journal-title":"JAMA Neurol"},{"key":"2035_CR82","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","volume":"125","author":"N Kouri","year":"2013","unstructured":"Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE et al (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741\u2013752. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1087-8","journal-title":"Acta Neuropathol"},{"key":"2035_CR83","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A et al (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247. \n                    https:\/\/doi.org\/10.1038\/ncomms8247","journal-title":"Nat Commun"},{"key":"2035_CR84","series-title":"Neuropathology","first-page":"355","volume-title":"Handbook of clinical neurology","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG (2018) Tauopthies. In: Kovacs GG, Alafuzoff I (eds) Handbook of clinical neurology, 3rd edn. Neuropathology, vol 145. Elsevier, Amsterdam, pp 355\u2013368"},{"key":"2035_CR85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5414\/NPP29271","volume":"29","author":"GG Kovacs","year":"2010","unstructured":"Kovacs GG, Budka H (2010) Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 29:271\u2013288","journal-title":"Clin Neuropathol"},{"key":"2035_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol"},{"key":"2035_CR87","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bpa.12536","volume":"27","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Lee VM, Trojanowski JQ (2017) Protein astrogliopathies in human neurodegenerative diseases and aging. Brain Pathol 27:675\u2013690. \n                    https:\/\/doi.org\/10.1111\/bpa.12536","journal-title":"Brain Pathol"},{"key":"2035_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-007-0322-6","volume":"116","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Pittman A, Revesz T, Luk C, Lees A, Kiss E et al (2008) MAPT S305I mutation: implications for argyrophilic grain disease. Acta Neuropathol 116:103\u2013118. \n                    https:\/\/doi.org\/10.1007\/s00401-007-0322-6","journal-title":"Acta Neuropathol"},{"key":"2035_CR89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnen\/nlx007","volume":"76","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA et al (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270\u2013288. \n                    https:\/\/doi.org\/10.1093\/jnen\/nlx007","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR90","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2990.2012.01272.x","volume":"39","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S et al (2013) Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 39:166\u2013178. \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.2012.01272.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","volume":"6","author":"GG Kovacs","year":"2018","unstructured":"Kovacs GG, Xie SX, Robinson JL, Lee EB, Smith DH, Schuck T et al (2018) Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathol Commun 6:50","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 6","key":"2035_CR92","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/mds.10563","volume":"18","author":"AE Lang","year":"2003","unstructured":"Lang AE (2003) Corticobasal degeneration: selected developments. Mov Disord 18(Suppl 6):S51\u201356. \n                    https:\/\/doi.org\/10.1002\/mds.10563","journal-title":"Mov Disord"},{"key":"2035_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12250","author":"T Lashley","year":"2015","unstructured":"Lashley T, Rohrer JD, Mead S, Revesz T (2015) Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol. \n                    https:\/\/doi.org\/10.1111\/nan.12250","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR94","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1679-9","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"2035_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nan.12037","volume":"40","author":"H Ling","year":"2014","unstructured":"Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N et al (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149\u2013163. \n                    https:\/\/doi.org\/10.1111\/nan.12037","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR96","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/brain\/aww256","volume":"139","author":"H Ling","year":"2016","unstructured":"Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J et al (2016) Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139:3237\u20133252. \n                    https:\/\/doi.org\/10.1093\/brain\/aww256","journal-title":"Brain"},{"key":"2035_CR97","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/mdc3.12581","volume":"5","author":"H Ling","year":"2018","unstructured":"Ling H, Macerollo A (2018) Is it useful to classify PSP and CBD as different disorders? Yes. Mov Disord Clin Pract 5:145\u2013148. \n                    https:\/\/doi.org\/10.1002\/mdc3.12581","journal-title":"Mov Disord Clin Pract"},{"key":"2035_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139","journal-title":"Neurology"},{"key":"2035_CR99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","volume":"55","author":"I Litvan","year":"1996","unstructured":"Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS et al (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97\u2013105","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR100","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/nan.12339","volume":"42","author":"A Martinez-Maldonado","year":"2016","unstructured":"Martinez-Maldonado A, Luna-Munoz J, Ferrer I (2016) Incidental corticobasal degeneration. Neuropathol Appl Neurobiol 42:659\u2013663. \n                    https:\/\/doi.org\/10.1111\/nan.12339","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp-2011-300875","volume":"83","author":"R Mathew","year":"2012","unstructured":"Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 83:405\u2013410. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-300875","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2035_CR102","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.neurobiolaging.2013.11.029","volume":"35","author":"CT McMillan","year":"2014","unstructured":"McMillan CT, Toledo JB, Avants BB, Cook PA, Wood EM, Suh E et al (2014) Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration. Neurobiol Aging 35:1473\u20131482. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.029","journal-title":"Neurobiol Aging"},{"key":"2035_CR103","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","volume":"13","author":"LH Meeter","year":"2017","unstructured":"Meeter LH, Kaat LD, Rohrer JD, van Swieten JC (2017) Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol 13:406\u2013419. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.75","journal-title":"Nat Rev Neurol"},{"key":"2035_CR104","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nbd.2017.03.011","volume":"109","author":"R Melki","year":"2018","unstructured":"Melki R (2018) How the shapes of seeds can influence pathology. Neurobiol Dis 109:201\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2017.03.011","journal-title":"Neurobiol Dis"},{"key":"2035_CR105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5414\/NP300515","volume":"32","author":"I Milenkovic","year":"2013","unstructured":"Milenkovic I, Kovacs GG (2013) Incidental corticobasal degeneration in a 76-year-old woman. Clin Neuropathol 32:69\u201372. \n                    https:\/\/doi.org\/10.5414\/NP300515","journal-title":"Clin Neuropathol"},{"key":"2035_CR106","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fneur.2018.00692","volume":"9","author":"M Montembeault","year":"2018","unstructured":"Montembeault M, Brambati SM, Gorno-Tempini ML, Migliaccio R (2018) Clinical, anatomical, and pathological features in the three variants of primary progressive aphasia: a review. Front Neurol 9:692. \n                    https:\/\/doi.org\/10.3389\/fneur.2018.00692","journal-title":"Front Neurol"},{"key":"2035_CR107","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/WNL.59.3.443","volume":"59","author":"HR Morris","year":"2002","unstructured":"Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW et al (2002) Analysis of tau haplotypes in Pick\u2019s disease. Neurology 59:443\u2013445","journal-title":"Neurology"},{"key":"2035_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt231","volume":"6","author":"ME Murray","year":"2014","unstructured":"Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P et al (2014) Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 6:1. \n                    https:\/\/doi.org\/10.1186\/alzrt231","journal-title":"Alzheimers Res Ther"},{"key":"2035_CR109","doi-asserted-by":"publisher","first-page":"e12840","DOI":"10.1111\/acel.12840","volume":"17","author":"N Musi","year":"2018","unstructured":"Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q et al (2018) Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17:e12840. \n                    https:\/\/doi.org\/10.1111\/acel.12840","journal-title":"Aging Cell"},{"key":"2035_CR110","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/brain\/awu256","volume":"137","author":"M Niethammer","year":"2014","unstructured":"Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S et al (2014) A disease-specific metabolic brain network associated with corticobasal degeneration. Brain 137:3036\u20133046. \n                    https:\/\/doi.org\/10.1093\/brain\/awu256","journal-title":"Brain"},{"key":"2035_CR111","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1272\/jnms.82.266","volume":"82","author":"A Nogami","year":"2015","unstructured":"Nogami A, Yamazaki M, Saito Y, Hatsuta H, Sakiyama Y, Takao M et al (2015) Early stage of progressive supranuclear palsy: a neuropathological study of 324 consecutive autopsy cases. J Nippon Med Sch 82:266\u2013273. \n                    https:\/\/doi.org\/10.1272\/jnms.82.266","journal-title":"J Nippon Med Sch"},{"key":"2035_CR112","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.10680","volume":"19","author":"Y Osaki","year":"2004","unstructured":"Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19:181\u2013189. \n                    https:\/\/doi.org\/10.1002\/mds.10680","journal-title":"Mov Disord"},{"key":"2035_CR113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-015-0531-7","volume":"15","author":"G Pasqualetti","year":"2015","unstructured":"Pasqualetti G, Brooks DJ, Edison P (2015) The role of neuroinflammation in dementias. Curr Neurol Neurosci Rep 15:17. \n                    https:\/\/doi.org\/10.1007\/s11910-015-0531-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2035_CR114","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awx254","volume":"140","author":"DC Perry","year":"2017","unstructured":"Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A et al (2017) Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain 140:3329\u20133345. \n                    https:\/\/doi.org\/10.1093\/brain\/awx254","journal-title":"Brain"},{"key":"2035_CR115","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/glia.23163","volume":"65","author":"R Piacentini","year":"2017","unstructured":"Piacentini R, Li Puma DD, Mainardi M, Lazzarino G, Tavazzi B, Arancio O et al (2017) Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons. Glia 65:1302\u20131316. \n                    https:\/\/doi.org\/10.1002\/glia.23163","journal-title":"Glia"},{"key":"2035_CR116","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0b013e318207b1ce","volume":"76","author":"O Piguet","year":"2011","unstructured":"Piguet O, Halliday GM, Reid WG, Casey B, Carman R, Huang Y et al (2011) Clinical phenotypes in autopsy-confirmed Pick disease. Neurology 76:253\u2013259. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318207b1ce","journal-title":"Neurology"},{"key":"2035_CR117","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.410430617","volume":"43","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L et al (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815\u2013825. \n                    https:\/\/doi.org\/10.1002\/ana.410430617","journal-title":"Ann Neurol"},{"key":"2035_CR118","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","volume":"14","author":"M Querol-Vilaseca","year":"2017","unstructured":"Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, San Martin-Paniello C, Clarimon J, Belbin O et al (2017) YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies. J Neuroinflammation 14:118. \n                    https:\/\/doi.org\/10.1186\/s12974-017-0893-7","journal-title":"J Neuroinflammation"},{"key":"2035_CR119","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/Nrneurol.2013.76","volume":"9","author":"R Rademakers","year":"2013","unstructured":"Rademakers R, Neumann M, Mackenzie IR (2013) Advances in understanding the molecular basis of frontotemporal dementia (vol 8, p 423, 2012). Nat Rev Neurol 9:423\u2013434. \n                    https:\/\/doi.org\/10.1038\/Nrneurol.2013.76","journal-title":"Nat Rev Neurol"},{"key":"2035_CR120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamaneurol.2016.2016","volume":"73","author":"KG Ranasinghe","year":"2016","unstructured":"Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW et al (2016) Distinct subtypes of behavioral variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol 73:1078\u20131088","journal-title":"JAMA Neurol"},{"key":"2035_CR121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0197-4580(00)00202-5","volume":"22","author":"LA Reed","year":"2001","unstructured":"Reed LA, Wszolek ZK, Hutton M (2001) Phenotypic correlations in FTDP-17. Neurobiol Aging 22:89\u2013107","journal-title":"Neurobiol Aging"},{"key":"2035_CR122","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766. \n                    https:\/\/doi.org\/10.1002\/mds.26054","journal-title":"Mov Disord"},{"key":"2035_CR123","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/nlw034","volume":"75","author":"RD Rodriguez","year":"2016","unstructured":"Rodriguez RD, Suemoto CK, Molina M, Nascimento CF, Leite RE, de Lucena Ferretti-Rebustini RE et al (2016) Argyrophilic grain disease: demographics, clinical, and neuropathological features from a large autopsy study. J Neuropathol Exp Neurol 75:628\u2013635. \n                    https:\/\/doi.org\/10.1093\/jnen\/nlw034","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR124","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/brain\/awr198","volume":"134","author":"JD Rohrer","year":"2011","unstructured":"Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM et al (2011) Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134:2565\u20132581","journal-title":"Brain"},{"key":"2035_CR125","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L et al (2015) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol 14:253\u2013262. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70324-2","journal-title":"Lancet Neurol"},{"key":"2035_CR126","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-013-1229-z","volume":"127","author":"A Ronnback","year":"2014","unstructured":"Ronnback A, Nennesmo I, Tuominen H, Grueninger F, Viitanen M, Graff C et al (2014) Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease. Acta Neuropathol 127:297\u2013298. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1229-z","journal-title":"Acta Neuropathol"},{"key":"2035_CR127","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jnen\/61.9.789","volume":"61","author":"Y Saito","year":"2002","unstructured":"Saito Y, Nakahara K, Yamanouchi H, Murayama S (2002) Severe involvement of ambient gyrus in dementia with grains. J Neuropathol Exp Neurol 61:789\u2013796","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR128","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnen\/63.9.911","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y et al (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911\u2013918","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR129","doi-asserted-by":"publisher","first-page":"E3830","DOI":"10.1073\/pnas.1617782114","volume":"114","author":"K Sakers","year":"2017","unstructured":"Sakers K, Lake AM, Khazanchi R, Ouwenga R, Vasek MJ, Dani A et al (2017) Astrocytes locally translate transcripts in their peripheral processes. Proc Natl Acad Sci USA 114:E3830\u2013E3838. \n                    https:\/\/doi.org\/10.1073\/pnas.1617782114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2035_CR130","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00401-012-1017-1","volume":"124","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Haggiagi A, Liu X, Wasserscheid J, Nelson PT, Dewar K et al (2012) The MAPT H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol 124:693\u2013704. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1017-1","journal-title":"Acta Neuropathol"},{"key":"2035_CR131","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41593-018-0325-8","volume":"22","author":"M Santello","year":"2019","unstructured":"Santello M, Toni N, Volterra A (2019) Astrocyte function from information processing to cognition and cognitive impairment. Nat Neurosci 22:154\u2013166. \n                    https:\/\/doi.org\/10.1038\/s41593-018-0325-8","journal-title":"Nat Neurosci"},{"issue":"Suppl 12","key":"2035_CR132","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/mds.20536","volume":"20","author":"T Scaravilli","year":"2005","unstructured":"Scaravilli T, Tolosa E, Ferrer I (2005) Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov Disord 20(Suppl 12):S21\u201328. \n                    https:\/\/doi.org\/10.1002\/mds.20536","journal-title":"Mov Disord"},{"key":"2035_CR133","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/13543784.2018.1460356","volume":"27","author":"A Shoeibi","year":"2018","unstructured":"Shoeibi A, Olfati N, Litvan I (2018) Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. Expert Opin Investig Drugs 27:349\u2013361. \n                    https:\/\/doi.org\/10.1080\/13543784.2018.1460356","journal-title":"Expert Opin Investig Drugs"},{"key":"2035_CR134","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mehy.2015.02.004","volume":"84","author":"RE Sica","year":"2015","unstructured":"Sica RE (2015) Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis. Med Hypotheses 84:481\u2013489. \n                    https:\/\/doi.org\/10.1016\/j.mehy.2015.02.004","journal-title":"Med Hypotheses"},{"key":"2035_CR135","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fncel.2018.00072","volume":"12","author":"SD Skaper","year":"2018","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P (2018) An Inflammation-centric view of neurological disease: beyond the neuron. Front Cell Neurosci 12:72. \n                    https:\/\/doi.org\/10.3389\/fncel.2018.00072","journal-title":"Front Cell Neurosci"},{"key":"2035_CR136","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Scholl M, Ohlsson T, van Swieten J, Honer M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372\u20132379","journal-title":"Brain"},{"key":"2035_CR137","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/s1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(13)70090-5","journal-title":"Lancet Neurol"},{"key":"2035_CR138","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.24885","volume":"81","author":"EG Spinelli","year":"2017","unstructured":"Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F et al (2017) Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 81:430\u2013443","journal-title":"Ann Neurol"},{"key":"2035_CR139","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/brain\/awy319","volume":"142","author":"AM Staffaroni","year":"2019","unstructured":"Staffaroni AM, Ljubenkov PA, Kornak J, Cobigo Y, Datta S, Marx G et al (2019) Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials. Brain 142:443\u2013459. \n                    https:\/\/doi.org\/10.1093\/brain\/awy319","journal-title":"Brain"},{"key":"2035_CR140","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1508","volume":"37","author":"H Stefansson","year":"2005","unstructured":"Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J et al (2005) A common inversion under selection in Europeans. Nat Genet 37:129\u2013137. \n                    https:\/\/doi.org\/10.1038\/ng1508","journal-title":"Nat Genet"},{"key":"2035_CR141","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/nan.12456","volume":"44","author":"P Strafela","year":"2018","unstructured":"Strafela P, Plesko J, Magdic J, Koritnik B, Zupan A, Glavac D et al (2018) Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions. Neuropathol Appl Neurobiol 44:550\u2013562. \n                    https:\/\/doi.org\/10.1111\/nan.12456","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR142","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/mtna.2014.30","volume":"3","author":"R Sud","year":"2014","unstructured":"Sud R, Geller ET, Schellenberg GD (2014) Antisense-mediated Exon skipping decreases Tau Protein Expression: a potential therapy for tauopathies. Mol Ther Nucleic Acids 3:e180","journal-title":"Mol Ther Nucleic Acids"},{"key":"2035_CR143","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00401-015-1425-0","volume":"130","author":"P Tacik","year":"2015","unstructured":"Tacik P, DeTure M, Lin WL, Sanchez Contreras M, Wojtas A, Hinkle KM et al (2015) A novel tau mutation, p. K317N, causes globular glial tauopathy. Acta Neuropathol 130:199\u2013214. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1425-0","journal-title":"Acta Neuropathol"},{"key":"2035_CR144","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/nan.12367","volume":"43","author":"P Tacik","year":"2017","unstructured":"Tacik P, Sanchez-Contreras M, DeTure M, Murray ME, Rademakers R, Ross OA et al (2017) Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p. P301L mutation, including a patient with globular glial tauopathy. Neuropathol Appl Neurobiol 43:200\u2013214","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR145","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.dadm.2015.12.004","volume":"2","author":"CE Teunissen","year":"2016","unstructured":"Teunissen CE, Elias N, Koel-Simmelink MJ, Durieux-Lu S, Malekzadeh A, Pham TV et al (2016) Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst) 2:86\u201394. \n                    https:\/\/doi.org\/10.1016\/j.dadm.2015.12.004","journal-title":"Alzheimers Dement (Amst)"},{"key":"2035_CR146","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00702-014-1360-6","volume":"122","author":"DR Thal","year":"2015","unstructured":"Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J et al (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm (Vienna) 122:1007\u20131018. \n                    https:\/\/doi.org\/10.1007\/s00702-014-1360-6","journal-title":"J Neural Transm (Vienna)"},{"key":"2035_CR147","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","volume":"61","author":"T Togo","year":"2002","unstructured":"Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M, de Silva R et al (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 61:547\u2013556","journal-title":"J Neuropathol Exp Neurol"},{"key":"2035_CR148","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s004010050642","volume":"93","author":"M Tolnay","year":"1997","unstructured":"Tolnay M, Spillantini MG, Goedert M, Ulrich J, Langui D, Probst A et al (1997) Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol 93:477\u2013484","journal-title":"Acta Neuropathol"},{"key":"2035_CR149","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/dds238","volume":"21","author":"D Trabzuni","year":"2012","unstructured":"Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C et al (2012) MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet 21:4094\u20134103. \n                    https:\/\/doi.org\/10.1093\/hmg\/dds238","journal-title":"Hum Mol Genet"},{"key":"2035_CR150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-007-0200-2","volume":"113","author":"T Uchihara","year":"2007","unstructured":"Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113:483\u2013499","journal-title":"Acta Neuropathol"},{"key":"2035_CR151","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s004010050934","volume":"96","author":"T Uchihara","year":"1998","unstructured":"Uchihara T, Mizusawa H, Tsuchiya K, Kondo H, Oda T, Ikeda K et al (1998) Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration. Acta Neuropathol 96:553\u2013557","journal-title":"Acta Neuropathol"},{"key":"2035_CR152","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2010.00433.x","volume":"21","author":"T Uchihara","year":"2011","unstructured":"Uchihara T, Nakamura A, Shibuya K, Yagishita S (2011) Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP\/CBD brains. Brain Pathol 21:180\u2013188. \n                    https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00433.x","journal-title":"Brain Pathol"},{"key":"2035_CR153","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004010000186","volume":"100","author":"T Uchihara","year":"2000","unstructured":"Uchihara T, Nakamura A, Yamazaki M, Mori O (2000) Tau-positive neurons in corticobasal degeneration and Alzheimer\u2019s disease\u2013distinction by thiazin red and silver impregnations. Acta Neuropathol 100:385\u2013389","journal-title":"Acta Neuropathol"},{"key":"2035_CR154","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I","volume":"46","author":"JC van Swieten","year":"1999","unstructured":"van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I et al (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 46:617\u2013626","journal-title":"Ann Neurol"},{"key":"2035_CR155","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-016-0185-y","volume":"8","author":"R Vandenberghe","year":"2016","unstructured":"Vandenberghe R (2016) Classification of the primary progressive aphasias: principles and review of progress since 2011. Alzheimers Res Ther 8:16. \n                    https:\/\/doi.org\/10.1186\/s13195-016-0185-y","journal-title":"Alzheimers Res Ther"},{"key":"2035_CR156","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2016.13","volume":"17","author":"DM Walsh","year":"2016","unstructured":"Walsh DM, Selkoe DJ (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17:251\u2013260. \n                    https:\/\/doi.org\/10.1038\/nrn.2016.13","journal-title":"Nat Rev Neurosci"},{"key":"2035_CR157","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00401-015-1416-1","volume":"129","author":"RO Weller","year":"2015","unstructured":"Weller RO, Hawkes CA, Carare RO, Hardy J (2015) Does the difference between PART and Alzheimer\u2019s disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Abeta and propagation of tau? Acta Neuropathol 129:763\u2013766. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1416-1","journal-title":"Acta Neuropathol"},{"key":"2035_CR158","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Hoglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C et al (2017) Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord 32:955\u2013971. \n                    https:\/\/doi.org\/10.1002\/mds.27038","journal-title":"Mov Disord"},{"key":"2035_CR159","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2012.7","volume":"8","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL, Josephs KA (2012) Neuroimaging in frontotemporal lobar degeneration\u2013predicting molecular pathology. Nat Rev Neurol 8:131\u2013142. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2012.7","journal-title":"Nat Rev Neurol"},{"key":"2035_CR160","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130:1566\u20131576. \n                    https:\/\/doi.org\/10.1093\/brain\/awm104","journal-title":"Brain"},{"key":"2035_CR161","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaneurol.2013.3956","volume":"70","author":"EM Wood","year":"2013","unstructured":"Wood EM, Falcone D, Suh E, Irwin DJ, Chen-Plotkin AS, Lee EB et al (2013) Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol 70:1411\u20131417. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.3956","journal-title":"JAMA Neurol"},{"key":"2035_CR162","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/nan.12247","volume":"42","author":"R Wood","year":"2016","unstructured":"Wood R, Moodley K, Hodges JR, Allinson K, Spillantini MG, Chan D et al (2016) Slowly progressive behavioural presentation in two UK cases with the R406\u00a0W MAPT mutation. Neuropathol Appl Neurobiol 42:291\u2013295. \n                    https:\/\/doi.org\/10.1111\/nan.12247","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR163","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1471-4159.2011.07446.x","volume":"119","author":"Q Yang","year":"2011","unstructured":"Yang Q, Wang EY, Huang XJ, Qu WS, Zhang L, Xu JZ et al (2011) Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats. J Neurochem 119:644\u2013653. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07446.x","journal-title":"J Neurochem"},{"key":"2035_CR164","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00401-009-0493-4","volume":"117","author":"O Yokota","year":"2009","unstructured":"Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, Mochizuki A, Tamaoka A et al (2009) Clinicopathological characterization of Pick\u2019s disease versus frontotemporal lobar degeneration with ubiquitin\/TDP-43-positive inclusions. Acta Neuropathol 117:429\u2013444. \n                    https:\/\/doi.org\/10.1007\/s00401-009-0493-4","journal-title":"Acta Neuropathol"},{"key":"2035_CR165","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-017-1693-y","volume":"133","author":"JS Yokoyama","year":"2017","unstructured":"Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA et al (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol 133:825\u2013837. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1693-y","journal-title":"Acta Neuropathol"},{"key":"2035_CR166","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.0022-3042.2001.00729.x","volume":"80","author":"H Yoshida","year":"2002","unstructured":"Yoshida H, Crowther RA, Goedert M (2002) Functional effects of tau gene mutations deltaN296 and N296H. J Neurochem 80:548\u2013551","journal-title":"J Neurochem"},{"key":"2035_CR167","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-016-1665-7","volume":"133","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N et al (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809\u2013823. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1665-7","journal-title":"Acta Neuropathol"},{"key":"2035_CR168","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1789.2006.00743.x","volume":"26","author":"M Yoshida","year":"2006","unstructured":"Yoshida M (2006) Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26:457\u2013470","journal-title":"Neuropathology"},{"key":"2035_CR169","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM et al (2018) Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun 9:4273. \n                    https:\/\/doi.org\/10.1038\/s41467-018-05892-0","journal-title":"Nat Commun"},{"key":"2035_CR170","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00415-014-7256-4","volume":"261","author":"N Zalewski","year":"2014","unstructured":"Zalewski N, Botha H, Whitwell JL, Lowe V, Dickson DW, Josephs KA et al (2014) FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol 261:710\u2013716. \n                    https:\/\/doi.org\/10.1007\/s00415-014-7256-4","journal-title":"J Neurol"},{"key":"2035_CR171","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/nan.12530","volume":"45","author":"H Zetterberg","year":"2019","unstructured":"Zetterberg H, van Swieten JC, Boxer AL, Rohrer JD (2019) Review: fluid biomarkers for frontotemporal dementias. Neuropathol Appl Neurobiol 45:81\u201387. \n                    https:\/\/doi.org\/10.1111\/nan.12530","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2035_CR172","doi-asserted-by":"publisher","first-page":"44994","DOI":"10.18632\/oncotarget.16690","volume":"8","author":"CC Zhang","year":"2017","unstructured":"Zhang CC, Zhu JX, Wan Y, Tan L, Wang HF, Yu JT et al (2017) Meta-analysis of the association between variants in MAPT and neurodegenerative diseases. Oncotarget 8:44994\u201345007. \n                    https:\/\/doi.org\/10.18632\/oncotarget.16690","journal-title":"Oncotarget"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02035-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T23:07:02Z","timestamp":1592089622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":172,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02035-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]},"assertion":[{"value":"5 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}